Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Public Health
Healthgrades Announces 2021 America’s Best Hospitals™
Life Sciences Times
-
February 9, 2021
0
Real Estate
New England Patriots Foundation Donates $100,000 to Cape Cod Community College for New STEM Building
Life Sciences Times
-
February 9, 2021
0
Medtech
Hacker changed water chemical levels to poison entire US city
Life Sciences Times
-
February 9, 2021
0
Biotech
BioAsia 2021 to focus on Covid, global health
Life Sciences Times
-
February 9, 2021
0
Public Health
Covid virus leak from lab ‘extremely unlikely,’ says WHO team
Life Sciences Times
-
February 9, 2021
0
Pharma
Global Anti-inflammatory Drugs Market to Surpass US$ 142,223.4 Million by 2027, Says Coherent Market Insights
Life Sciences Times
-
February 8, 2021
0
Pharma
COVAXX’s COVID-19 Vaccine, UB-612, Induced Neutralizing Antibodies in 100% of Participants During Phase 1 Clinical Trial
Life Sciences Times
-
February 8, 2021
0
Public Health
US sees drop in Covid cases, deaths, hospitalizations
Life Sciences Times
-
February 8, 2021
0
Medtech
Novel AI tool to thwart Covid mutations
Life Sciences Times
-
February 8, 2021
0
Public Health
UK plans annual vaccinations against new Covid variants
Life Sciences Times
-
February 8, 2021
0
1
...
780
781
782
...
805
Page 781 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026